On March 28, 2023, the third reelection conference and tenth anniversary celebration of Shenzhen Life Technology Industry-Academy-Research Funding Alliance were successfully held in Shenzhen. Beike Biotechnology won the “Industry Pioneer Award” for its outstanding contributions to the development of the life sciences and biotechnology industries, which fully demonstrates the recognition of Beike Biotechnology’s scientific research capabilities, brand influence and good reputation by industry organizations and all walks of life.
The global health industry is in a period of rapid development, with new technologies and products constantly emerging. Cutting-edge technologies represented by stem cells, immune cells and other cell therapies have made significant progress in many fields such as tumors, tissue regeneration, and overcoming refractory diseases, and have become the focus of attention and development in developed countries. As one of the areas with the greatest development potential in the biomedical industry, the country has also introduced a series of policies to promote the development of the cell industry. With the release of my country’s first five-year bioeconomy plan, cell therapy has become an important part of it! As a pioneer demonstration zone for building socialism with Chinese characteristics, Shenzhen has listed the cell and gene industry as the key development direction of Shenzhen’s future industries. It has successively issued multiple policy documents such as the “Shenzhen 14th Five-Year Plan for Scientific and Technological Innovation”, the “20+8” industrial support policy, and the “Shenzhen Special Economic Zone Cell and Gene Industry Promotion Regulations”. It focuses on the deep integration of the innovation chain, industrial chain, capital chain and talent chain, and strives to promote the development into a strategic emerging industry within 5-10 years.
Beike Biotechnology, as a leader in the development of the cell industry, has insight into the development direction and key underlying core of the industry. In recent years, relying on its core technological advantages in the field of cells and its keen control of cutting-edge medical changes, Beike Biotechnology has frequently made breakthroughs in basic cell research, cell storage, metabolomics, new drug research and development, AI intelligence, big data and other fields, and the company’s various businesses have developed rapidly. In the future, Beike Biotech will keep up with the country’s progress and continue to focus on key scientific issues and cutting-edge technologies in the field of stem cells and regenerative medicine, starting from “industry innovation, talent innovation, technology innovation, product innovation” and other aspects. font-size: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline;”>Strengthen the collaborative linkage between industry, academia and research, accelerate the transformation and clinical application of related technology products, enhance core competitiveness, and promote the development of China’s cell industry.